Wang, Y., Zhang, H., & He, Y. (2019). The Complement Receptors C3aR and C5aR Are a New Class of Immune Checkpoint Receptor in Cancer Immunotherapy. Front Immunol.
Citação norma ChicagoWang, Yu, Hui Zhang, and You-Wen He. "The Complement Receptors C3aR and C5aR Are a New Class of Immune Checkpoint Receptor in Cancer Immunotherapy." Front Immunol 2019.
MLA CitationWang, Yu, Hui Zhang, and You-Wen He. "The Complement Receptors C3aR and C5aR Are a New Class of Immune Checkpoint Receptor in Cancer Immunotherapy." Front Immunol 2019.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.